CD8A and cancer: Since we did not observe significant differences in the tumor repertoire between the control and aCD4 groups by analyses of the tumor compartment alone, we focused on the overlapping clones between dLN CD44hi and tumor (dLN-tumor overlap), which are thought to represent CD8+ T cells actively participating in the Cancer-Immunity Cycle.